Type 1 Diabetes

TRIGR logo

TRIGR (Trial to Reduce IDDM in the Genetically at Risk) is an international, randomized, double-blinded trial. The hypothesis to be tested is whether hydrolyzed infant formula compared to cow's milk-based formula decreases risk of developing type 1 diabetes in children with increased genetic susceptibility. Recruitment is completed; no more babies will be enrolled.

Click for more

can we protect our children?

 

For more information about this study in your country, please click on your flag:

Australia Canada Czech Republic Estonia Finland Germany Hungary Italy Luxembourg Netherlands Poland Spain Sweden Switzerland United States

TRIGR is Sponsored By:

We acknowledge support from the
EC 5th Framework Programme
via project QLK1 CT 2002 00372
Diabetes Prevention
   


Study Formula Provided By:

Mead Johnson Nutritionals

 

 

Australia Canada Czech Rebublic Estonia Finland Germany Hungary Italy Luxembourg Netherlands Poland Spain Sweden Switzerland United States